NCT05862948 (ACCENDO-Colo) is a NA clinical trial of ENDO-Aid by Olympus in Adenoma Colon, sponsored by Fondazione Poliambulanza Istituto Ospedaliero.

Who is sponsoring NCT05862948?

NCT05862948 is sponsored by Fondazione Poliambulanza Istituto Ospedaliero.

What drugs are being tested in NCT05862948?

Interventions in NCT05862948: ENDO-Aid by Olympus.

What condition does NCT05862948 study?

NCT05862948 studies Adenoma Colon, Colonic Adenoma.

Is NCT05862948 still recruiting?

NCT05862948 is currently completed. Last updated 17 May 2023.

Last reviewed 2023-05-17 · How we verify

NCT05862948: ACCENDO-Colo

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Accuracy of Endo-aid in Consecutive Patients Referred for Colonoscopy

Completed NA Last updated 17 May 2023

What this trial tests

NA trial testing ENDO-Aid by Olympus in Adenoma Colon in 1,160 participants. Completed in 30 April 2023.

Timeline

30 October 2021

Primary endpoint
31 March 2023

30 April 2023

Quick facts

Lead sponsor	Fondazione Poliambulanza Istituto Ospedaliero
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	diagnostic
Enrollment	1,160
Start date	30 October 2021
Primary completion	31 March 2023
Estimated completion	30 April 2023
Sites	2 locations across Italy

Drugs / interventions tested

ENDO-Aid by Olympus

Conditions studied

Adenoma Colon — all drugs for Adenoma Colon →
Colonic Adenoma — all drugs for Colonic Adenoma →

Sponsor

Fondazione Poliambulanza Istituto Ospedaliero — full company profile →

Who can join

Adults 18 to 85, any sex, with Adenoma Colon or Colonic Adenoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to evaluate the diagnostic yield of CADe in a consecutive population undergoing colonoscopy. The main question it aims to answer is the Adenoma Detection Rate (ADR). Participants undergoing colonoscopy will be randomized in a 1:1 ratio to either receive Computer-Aided Detection (CADe) colonoscopy or a conventional colonoscopy (CC). Researchers will compare the CADe group and the CC-group to see if CAD-e can increase the ADR significantly.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

A comprehensive RCT in screening, surveillance, and diagnostic AI-assisted colonoscopies (ACCENDO-Colo study).
Spada C, Salvi D, Ferrari C, Hassan C, et al · · 2025 · cited 5× · PMID 39814659 · DOI 10.1016/j.dld.2024.12.023

Verify or expand the search:

Other recruiting trials for Adenoma Colon

Currently open trials in the same condition.

NCT07153458 — Identification of New Non-invasive, Predictive, and Diagnostic Biomarkers for Colorectal Cancer · recruiting
NCT07033156 — An Exploratory Study on Gene Methylation Detection of Colorectal Cancer · recruiting
NCT07450612 — Liquid Biopsy and Machine Learning for Early Colorectal Cancer, Adenomas, Lynch Cancers, and Residual Disease Detection · recruiting
NCT06073561 — Underwater Endoscopic Mucosal Resection · NA · recruiting
NCT04756453 — The Effect of Clip-traction on ESD Resection Time. · NA · recruiting

Other Fondazione Poliambulanza Istituto Ospedaliero trials

Trials by the same sponsor.

NCT07111715 — Comparison Between Artificial Intelligence and Standard Reading to Investigate Suspected Crohn Disease: the SCAI STUDY · recruiting
NCT06068023 — The ADAPTA Study: ADjuvant chemotherAPy After Curative Intent resecTion of Ampullary Cancer. · recruiting
NCT05475041 — Perioperative Outcomes of Simultaneous Colorectal and Liver Resections · completed
NCT05478889 — Minimally Invasive Pancreatoduodenectomy for Distal Cholangiocarcinoma · completed
NCT05138094 — LIVACOR Trial: Minimally Invasive LIVer And Simultaneous COlorectal Resection · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05862948 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Fondazione Poliambulanza Istituto Ospedaliero
Last refreshed: 17 May 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05862948.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing